BIOMAT Database Logo BIOMAT Database Logo

Melanoma patient antibody responses to melanoma tumor-associated antigens defined by murine monoclonal antibodies. 1989

H F Seigler, and M K Wallack, and C E Vervaert, and J A Bash, and K M Roberson, and G M Stuhlmiller
Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710.

Sera from melanoma patients undergoing immunization with three distinct immunogens were evaluated for development of IgG antibody specific for the melanoma tumor-associated antigens (TAAs) GD3 and 250-kd glycoprotein (high molecular weight; HMW). Of 99 patients receiving either irradiated allogeneic melanoma cells admixed with bacillus Calmette-Guérin, vaccinia viral oncolysate melanoma cell membranes, or cholesterol hemisuccinate-modified melanoma cells, 12 were determined to have responded against GD3 and 17 against the HMW TAA. This reactivity was measured using both direct binding to purified TAA and specific inhibition of binding of murine monoclonal antibodies R24 and Me-1-14 for GD3 and HMW TAA, respectively. Preimmune sera from these patients did not react with these TAAs, nor did preimmune sera or follow-up sera from melanoma patients electing not to receive immunotherapy. These results suggest that melanoma patients can be immunized against these TAAs as presented on the melanoma cell membrane in an immunotherapy setting and that immunization using purified TAAs might likewise be feasible.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007115 Immunization Schedule Schedule giving optimum times usually for primary and/or secondary immunization. Immunization Schedules,Schedule, Immunization,Schedules, Immunization
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D012015 Reference Standards A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy. Standard Preparations,Standards, Reference,Preparations, Standard,Standardization,Standards,Preparation, Standard,Reference Standard,Standard Preparation,Standard, Reference
D002788 Cholesterol Esters Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis. Cholesterol Ester,Cholesteryl Ester,Cholesteryl Esters,Ester, Cholesterol,Ester, Cholesteryl,Esters, Cholesterol,Esters, Cholesteryl
D005732 Gangliosides A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997) Ganglioside,Sialoglycosphingolipids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

H F Seigler, and M K Wallack, and C E Vervaert, and J A Bash, and K M Roberson, and G M Stuhlmiller
Tumor-associated glycolipid antigens defined by monoclonal antibodies.
January 1983, Bulletin du cancer,
H F Seigler, and M K Wallack, and C E Vervaert, and J A Bash, and K M Roberson, and G M Stuhlmiller
Human tumor-associated antigens defined by monoclonal antibodies.
January 1984, Critical reviews in immunology,
H F Seigler, and M K Wallack, and C E Vervaert, and J A Bash, and K M Roberson, and G M Stuhlmiller
Canine lymphoma-associated antigens defined by murine monoclonal antibodies.
January 1987, Cancer immunology, immunotherapy : CII,
H F Seigler, and M K Wallack, and C E Vervaert, and J A Bash, and K M Roberson, and G M Stuhlmiller
Immunogenicity of human melanoma-associated antigens defined by murine monoclonal antibodies in allogeneic and xenogeneic hosts.
October 1987, Cancer research,
H F Seigler, and M K Wallack, and C E Vervaert, and J A Bash, and K M Roberson, and G M Stuhlmiller
Human prostate tissue antigens defined by murine monoclonal antibodies.
January 1986, Cancer research,
H F Seigler, and M K Wallack, and C E Vervaert, and J A Bash, and K M Roberson, and G M Stuhlmiller
Breast-cancer-associated antigens defined by monoclonal antibodies.
January 1988, Sub-cellular biochemistry,
H F Seigler, and M K Wallack, and C E Vervaert, and J A Bash, and K M Roberson, and G M Stuhlmiller
Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantisera.
January 1982, Cancer immunology, immunotherapy : CII,
H F Seigler, and M K Wallack, and C E Vervaert, and J A Bash, and K M Roberson, and G M Stuhlmiller
Antigens associated with human squamous cell lung carcinoma defined by murine monoclonal antibodies.
June 1986, Cancer research,
H F Seigler, and M K Wallack, and C E Vervaert, and J A Bash, and K M Roberson, and G M Stuhlmiller
Biochemical analysis of human ovarian cancer-associated antigens defined by murine monoclonal antibodies.
February 1985, Cancer research,
H F Seigler, and M K Wallack, and C E Vervaert, and J A Bash, and K M Roberson, and G M Stuhlmiller
Analysis of antibody responses directed against two Onchocerca volvulus antigens defined by monoclonal antibodies.
March 1992, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ),
Copied contents to your clipboard!